News & Updates

Pulmonary vascular resistance (PVR) may be used to distinguish severe (PVR >4 Wood Units) from nonsevere pulmonary hypertension (PVR ≤4 Wood Units) among patients with bronchiectasis-associated pulmonary hypertension (BAPH) and identify those who are at higher risk of mortality, a study suggests.

Patients with a diagnosis of lymphangioleiomyomatosis (LAM) are at higher risk of developing lung cancer, reveals a recent study.

A high mortality risk hounds patients with acute exacerbation (AE) of fibrotic interstitial lung disease (FILD) despite treatment with corticosteroids, reports a study, noting that such risk is similar to that seen in those with AE of idiopathic pulmonary fibrosis (IPF).

Supplementing standard COVID-19 treatment with Spirulina – a nutrient-rich superfood – may improve recovery and reduce mortality in hospitalized COVID-19 patients, a study from Iran suggests.